We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$142M
AUM Growth
+$13.4M
Cap. Flow
+$14.1M
Cap. Flow %
9.94%
Top 10 Hldgs %
47.14%
Holding
305
New
109
Increased
74
Reduced
18
Closed
8

Top Buys

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$5.88M
2
GE icon
GE Aerospace
GE
+$795K
3
ORCL icon
Oracle
ORCL
+$643K
4
SLB icon
SLB Ltd
SLB
+$584K
5
JNJ icon
Johnson & Johnson
JNJ
+$584K

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Energy 15.94%
3 Financials 12.57%
4 Healthcare 10.05%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICLN icon
276
iShares Global Clean Energy ETF
ICLN
$2.35B
$3K ﹤0.01%
300
JPC icon
277
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
$3K ﹤0.01%
+300
New +$2.8K
GM.WS.B
278
DELISTED
General Motors Company
GM.WS.B
$3K ﹤0.01%
198
+5
+3% +$72
UTEK
279
DELISTED
Ultratech Inc.
UTEK
$3K ﹤0.01%
140
QGENF
280
DELISTED
QIAGEN NV
QGENF
$3K ﹤0.01%
124
CORT icon
281
Corcept Therapeutics
CORT
$12.2B
$2K ﹤0.01%
700
DDD icon
282
3D Systems Corp
DDD
$462M
$2K ﹤0.01%
+60
New +$2.17K
DRRX
283
DELISTED
DURECT Corp
DRRX
$2K ﹤0.01%
300
JRS icon
284
Nuveen Real Estate Income Fund
JRS
$250M
$2K ﹤0.01%
+150
New +$1.68K
RFG icon
285
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$343M
$2K ﹤0.01%
75
TURN
286
DELISTED
180 Degree Capital
TURN
$2K ﹤0.01%
200
DNOW icon
287
DNOW Inc
DNOW
$2.6B
$1K ﹤0.01%
+25
New +$684
DVAX
288
DELISTED
Dynavax Technologies
DVAX
$1K ﹤0.01%
30
HQH
289
abrdn Healthcare Investors
HQH
$1.27B
$1K ﹤0.01%
18
-1,004
-98% -$30.2K
AFFX
290
DELISTED
Affymetrix Inc
AFFX
$1K ﹤0.01%
140
MCP
291
DELISTED
MOLYCORP INC COM STK
MCP
$1K ﹤0.01%
1,500
AGNC icon
292
AGNC Investment
AGNC
$12.4B
-375
Closed -$8K
BCLI
293
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$0 ﹤0.01%
+4
New +$210
BIB icon
294
ProShares Ultra NASDAQ Biotechnology
BIB
$77.8M
-600
Closed -$31K
FEZ icon
295
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.46B
-901
Closed -$36K
IGSB icon
296
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
-426
Closed -$22K
NG icon
297
NovaGold Resources
NG
$2.61B
-6,000
Closed -$18K
PGX icon
298
Invesco Preferred ETF
PGX
$3.8B
-1,779
Closed -$26K
RF icon
299
Regions Financial
RF
$26.9B
-500
Closed -$5K
RIG icon
300
Transocean
RIG
$5.7B
-200
Closed -$6K

Similar funds

Blume Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Blume Capital Management held 305 positions worth $142M, up 10% from $129M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Blume Capital Management deployed $14.1M of net new capital in Q4 2014, opening 109 new positions and adding to 74 existing holdings. Its largest new stake was Range Resources: 90,900 shares worth $4.86M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Occidental Petroleum, an estimated $3.59M trimmed.

  • Blume Capital Management's largest Q4 2014 buy was Range Resources: 90,900 shares worth $4.86M.
  • Blume Capital Management added most to GE Aerospace in Q4 2014, an estimated $795K increase.
  • Blume Capital Management's biggest Q4 2014 reduction was Occidental Petroleum, cutting an estimated $3.59M.
  • Blume Capital Management fully exited State Street SPDR EURO STOXX 50 ETF in Q4 2014, selling an estimated $36K.
  • Blume Capital Management's ten largest holdings make up 47% of its $142M portfolio in Q4 2014.
  • Blume Capital Management opened 109 new positions and closed 8 in Q4 2014.
  • Blume Capital Management's portfolio value rose 10% quarter-over-quarter to $142M.

Based on Blume Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.